Skip to main content
Withus Pharmaceutical. Co., LTD logo

Withus Pharmaceutical. Co., LTD — Investor Relations & Filings

Ticker · 330350 ISIN · KR7330350000 KO Manufacturing
Open in API
Filings indexed 119 across all filing types
Latest filing 2024-03-14 Proxy Solicitation & In…
Country KR South Korea
Listing KO 330350

About Withus Pharmaceutical. Co., LTD

https://withuspharm.com/

Withus Pharmaceutical. Co., LTD. is a pharmaceutical company engaged in the manufacturing and sale of prescription drugs. The company's product portfolio addresses a range of therapeutic areas, with a focus on circulatory agents, endocrine system treatments, and musculoskeletal drugs. Additionally, its offerings include antibiotics and medications for allergies.

Recent filings

Filing Released Lang Actions
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy) and contains detailed information regarding the upcoming Annual General Meeting (AGM) of Withus Pharmaceutical Co., Ltd., including the agenda, voting procedures, and financial statements (balance sheet, income statement, etc.) for the fiscal year 2023. This document is a standard proxy solicitation statement used to request shareholder votes for an AGM. In the provided classification schema, 'Proxy Solicitation & Information Statement' (PSI) is the correct category for such filings.
2024-03-14 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Withers Pharmaceutical. It outlines the date, location, agenda items (financial statements, director/auditor appointments, and remuneration limits), and details regarding the nominees. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2024-03-04 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 1% confidence The document is a formal announcement from Withers Pharmaceutical regarding the decision to pay cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the expected payment date. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2024-03-04 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal regulatory filing titled '주주총회 집중일 개최 사유 신고' (Report on the reason for holding a general meeting on a concentrated date). It explains why the company, Withus Pharmaceutical, is holding its shareholder meeting on a date that coincides with many other companies' meetings. This is a specific regulatory disclosure requirement in the Korean market, which does not fit into the other categories like AGM-R (presentation materials) or PSI (proxy solicitation). Therefore, it is classified as a general regulatory filing.
2024-03-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and their special relations (in this case, the resignation of an executive). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-02-29 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (Withus Pharmaceutical) announcing a significant change (over 15-30%) in revenue and profit structure compared to the previous fiscal year. This is a standard 'Earnings Release' (ER) type filing in the Korean market, providing key financial highlights and the reasons for the variance before the final audited annual report is published. FY 2023
2024-02-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.